Roger White to Humans
This is a "connection" page, showing publications Roger White has written about Humans.
Connection Strength
0.068
-
A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. Pharmacotherapy. 2003 Jul; 23(7):925-32.
Score: 0.008
-
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. Diagn Microbiol Infect Dis. 2002 Jul; 43(3):207-17.
Score: 0.008
-
What in vitro models of infection can and cannot do. Pharmacotherapy. 2001 Nov; 21(11 Pt 2):292S-301S.
Score: 0.008
-
Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis. 2000 Jul; 31(1):16-23.
Score: 0.007
-
A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis. Pharmacotherapy. 1999 May; 19(5):620-6.
Score: 0.006
-
A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro. Bull Math Biol. 1996 Sep; 58(5):923-38.
Score: 0.005
-
Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. J Clin Microbiol. 1991 Feb; 29(2):398-400.
Score: 0.004
-
Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomy. Drugs. 1988; 35 Suppl 2:72-7.
Score: 0.003
-
Differences in antimicrobial drug exposure in patients with various degrees of renal function based on recommendations from dosing references. Pharmacotherapy. 2002 Sep; 22(9):1097-104.
Score: 0.002
-
Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis. 2000 Sep; 38(1):43-50.
Score: 0.002
-
Pharmacokinetics of cefepime in patients with thermal burn injury. Antimicrob Agents Chemother. 1999 Dec; 43(12):2848-54.
Score: 0.002
-
Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis. 1999 May; 28(5):1017-24.
Score: 0.002
-
In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 1997 Sep; 41(9):2053-6.
Score: 0.001
-
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution. Am J Health Syst Pharm. 1996 Nov 15; 53(22):2731-4.
Score: 0.001
-
The costs of burn care: an analysis with an emphasis on the use of parenteral antimicrobials. J Burn Care Rehabil. 1994 May-Jun; 15(3):244-50.
Score: 0.001
-
Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma. Am J Hosp Pharm. 1992 Mar; 49(3):590-4.
Score: 0.001
-
Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations. Pharmacotherapy. 1992; 12(1):50-5.
Score: 0.001
-
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties. Clin Ther. 1991 Sep-Oct; 13(5):596-605.
Score: 0.001
-
In vivo inactivation of tobramycin by piperacillin. DICP. 1991 Apr; 25(4):357-9.
Score: 0.001
-
Aztreonam pharmacokinetics in burn patients. Antimicrob Agents Chemother. 1991 Jan; 35(1):57-61.
Score: 0.001
-
Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res. 1990 Nov; (260):17-23.
Score: 0.001
-
Effects of supraphysiologic temperature and broth dilution on serum protein binding. Antimicrob Agents Chemother. 1990 Jun; 34(6):1257-8.
Score: 0.001
-
Pharmacodynamics of trimethoprim-sulfamethoxazole in Listeria meningitis: a case report. Pharmacotherapy. 1990; 10(4):301-4.
Score: 0.001
-
The effect of tourniquet inflation on cefazolin tissue penetration during total knee arthroplasty. Pharmacotherapy. 1990; 10(6):373-7.
Score: 0.001